Medical abortion at home and at hospital: A trial of efficacy and acceptability;Interruption volontaire de grossesse médicamenteuse à domicile et à l'hôpital: Étude d'efficacité et d'acceptabilité

Gynecologie Obstetrique et Fertilite

Volumn 37, Issue 11-12, 2009, Pages 850-856

  Provansal, M ^a   Mimari, R ^a   Gregoire B ^a   Agostini, A ^a   Thirion, X ^b   Gamerre, M ^a  

^a HÔPITAL DE LA CONCEPTION   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Acceptability; Efficacy; Failure rates; Medical abortion; Mifepristone

Indexed keywords

MIFEPRISTONE;

ADULT; ARTICLE; ASPIRATION; CONSULTATION; CONTROLLED STUDY; EMERGENCY; FAMILY PLANNING; FEMALE; FOLLOW UP; GYNECOLOGY; HOME; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MEDICAL ABORTION; MEDICAL SPECIALIST; PREGNANCY;

EID: 70450239541     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/j.gyobfe.2009.07.016     Document Type: Article

References (22)

1. B. Couzinet, N. LeStrat, A. Ulmann, E. Baulieu, and G. Schaison Termination of early pregnancy by the progesterone antagonist RU 486 (mifepristone) N Engl J Med 315 1986 1565 1570
2. A. Ulmann, L. Silvestre, L. Chemama, Y. Rezvani, M. Renault, C. Aguillaume, et al. Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue Acta Obstet Gynecol Scand 71 1992 278 283
3. J. Kahn, B. Becker, L. MacIsaa, J. Amory, J. Neuhaus, I. Olkin, et al. The efficacy of medical abortion: a meta-analysis Contraception 61 2000 29 40
4. P. Faucher, N. Baunot, and P. Madelenat The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked with the hospital: a prospective study of 433 patients Gynecol Obstet Fertil 33 2005 220 227
5. R. Hausknecht Mifepristone and misoprostol for early medical abortion: 18 months experience in the United States Contraception 67 2003 463 465
6. o 156 du 7 juillet 2001, p. 10823.
7. Prise en charge de l'interruption volontaire de grossesse jusqu'à 14 semaines. Anaes. Mars 2001. www.anaes.fr [consulté en février 2008].
8. o 105 du 5 mai 2002, p. 8658.
9. o 173 du 28 juillet 2004, p. 13433.
10. B. Winikoff, C. Ellertson, and S. Clark Analysis of failure in medical abortion Contraception 54 1996 323 327
11. A. Hedley, J. Trussell, A. Turner, K. Coyaji, N. Ngoc, and B. Winikoff Differences in efficacy, differences in providers: results from a hazard analysis of medical abortion Contraception 69 2004 157 163 (Pubitemid 38167467)
12. E. Pirruccello, M. Newhall, and B. Winikoff Abortion with mifepristone and misoprostol: regimens, efficacy, acceptability and future directions Am J Obstet Gynecol 183 2000 S44 S53
13. G. Beucher, M. Beillat, and M. Dreyfus Prise en charge des fausses couches spontanées du premier trimestre J Gynecol Obstet Biol Reprod (Paris) 32 2003 5 21
14. C. Fiala, P. Safar, M. Bygdeman, and K. Gemzell-Danielsson Verifying the effectiveness of medical abortion; ultrasound versus hCG testing Eur J Obstet Gynecol Reprod Biol 109 2003 190 195
15. C. Rorbye, M. Norgaard, and L. Nilas Prediction of late failure after medical abortion from serial beta-hCG measurements and ultrasonography Hum Reprod 19 2004 85 89
16. M.F. Gallo, S. Cahill, L. Castleman, and E.M. Mitchell A systematic review of more than one dose of misoprostol after mifepristone for abortion up to 10 weeks of gestation Contraception 74 2006 36 41
17. I. Dagousset, E. Fourrier, E. Aubény, and R. Taurelle Use of Misoprostol for medical abortion : a trial of the acceptability for home use Gynecol Obstet Fertil 32 2004 28 33
18. J.P. Guengant, J. Bangou, B. Elul, and C. Ellertson Mifepristone- misoprostol medical abortion: home administration of misoprostol in Guadeloupe Contraception 60 1999 167 172
19. E.A. Schaff, L.S. Stadalius, S.H. Eisinger, and P. Franks Vaginal misoprostol administered at home after mifepristone (RU486) for abortion J Fam Pract 44 1997 353 360
20. J. Blum, S. Hajri, H. Chélli, F.B. Mansour, N. Gueddana, and B. Winikoff The medical abortion experiences of married and unmarried women in Tunis, Tunisia Contraception 69 2004 63 69 (Pubitemid 38076969)
21. N.T. Ngoc, V.Q. Nhan, J. Blum, T.T. Mai, J.M. Durocher, and B. Winikoff Is home-based administration of prostaglandin safe and feasible for medical abortion? Results from a multisite study in Vietnam BJOG 111 2004 814 819
22. B. Elul, E. Pearlman, A. Sorhaindo, W. Simonds, and C. Westhoff In-depth interviews with medical abortion clients: thoughts on the method and home administration of misoprostol J Am Med Womens Assoc 55 3 Suppl. 2000 169 172